$CLIR
ClearSign Technologies Corp

2024 Q3 Form 10-Q Financial Statement

#000155837024012226 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $1.859M $45.00K $150.0K
YoY Change 2087.06% -70.0%
Cost Of Revenue $1.308M $3.000K $21.00K
YoY Change 2044.26% -85.71%
Gross Profit $551.0K $42.00K $129.0K
YoY Change 2195.83% -67.44%
Gross Profit Margin 29.64% 93.33% 86.0%
Selling, General & Admin $1.571M
YoY Change 6.73%
% of Gross Profit 1217.83%
Research & Development $329.0K $402.0K $187.0K
YoY Change 253.76% 114.97% -0.53%
% of Gross Profit 59.71% 957.14% 144.96%
Depreciation & Amortization $4.000K $4.000K $78.00K
YoY Change -94.29% -94.87% 116.67%
% of Gross Profit 0.73% 9.52% 60.47%
Operating Expenses $1.984M $2.179M $1.758M
YoY Change 30.44% 23.95% 5.9%
Operating Profit -$1.433M -$2.137M -$1.629M
YoY Change -4.28% 31.18% -1.87%
Interest Expense $146.0K $94.00K
YoY Change 62.22%
% of Operating Profit
Other Income/Expense, Net $278.0K $265.0K $151.0K
YoY Change 68.48% 75.5% 586.36%
Pretax Income -$1.478M
YoY Change -9.77%
Income Tax
% Of Pretax Income
Net Earnings -$1.155M -$1.872M -$1.478M
YoY Change -13.29% 26.66% -9.77%
Net Earnings / Revenue -62.13% -4160.0% -985.33%
Basic Earnings Per Share -$0.02 -$0.04 -$0.04
Diluted Earnings Per Share -$0.04 -$0.04
COMMON SHARES
Basic Shares Outstanding 50.21M 39.04M 38.55M
Diluted Shares Outstanding 47.31M 38.55M

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.531M
YoY Change -5.28%
Cash & Equivalents $14.49M $15.97M $7.600M
Short-Term Investments $931.0K
Other Short-Term Assets $575.0K
YoY Change -4.96%
Inventory
Prepaid Expenses
Receivables $749.0K $135.0K $39.00K
Other Receivables $0.00
Total Short-Term Assets $15.99M $16.70M $9.148M
YoY Change 104.71% 82.58% -9.41%
LONG-TERM ASSETS
Property, Plant & Equipment $245.0K $271.0K $478.0K
YoY Change -39.66% -43.31% 0.21%
Goodwill
YoY Change
Intangibles $855.0K $855.0K $762.0K
YoY Change 11.18% 12.2% -6.16%
Long-Term Investments
YoY Change
Other Assets $10.00K
YoY Change 0.0%
Total Long-Term Assets $1.100M $1.126M $1.250M
YoY Change -7.17% -9.92% -3.77%
TOTAL ASSETS
Total Short-Term Assets $15.99M $16.70M $9.148M
Total Long-Term Assets $1.100M $1.126M $1.250M
Total Assets $17.09M $17.83M $10.40M
YoY Change 89.98% 71.46% -8.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.486M $453.0K $428.0K
YoY Change 266.01% 5.84% 20.22%
Accrued Expenses $401.0K $430.0K $413.0K
YoY Change -30.98% 4.12% 44.91%
Deferred Revenue $174.0K $825.0K $2.105M
YoY Change -90.34% -60.81% 2405.95%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.143M $1.796M $3.041M
YoY Change -25.23% -40.94% 219.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $199.0K
YoY Change -21.03%
Total Long-Term Liabilities $199.0K
YoY Change -21.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.143M $1.796M $3.041M
Total Long-Term Liabilities $199.0K
Total Liabilities $2.271M $1.939M $3.240M
YoY Change -25.59% -40.15% 169.1%
SHAREHOLDERS EQUITY
Retained Earnings -$97.85M -$96.70M -$91.43M
YoY Change 5.44% 5.76% 6.44%
Common Stock $5.000K $5.000K $4.000K
YoY Change 25.0% 25.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.158M
YoY Change
Total Liabilities & Shareholders Equity $17.09M $17.83M $10.40M
YoY Change 89.98% 71.46% -8.77%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.155M -$1.872M -$1.478M
YoY Change -13.29% 26.66% -9.77%
Depreciation, Depletion And Amortization $4.000K $4.000K $78.00K
YoY Change -94.29% -94.87% 116.67%
Cash From Operating Activities $46.00K
YoY Change -102.49%
INVESTING ACTIVITIES
Capital Expenditures $32.00K
YoY Change -180.0%
Acquisitions
YoY Change
Other Investing Activities $2.270M
YoY Change 16114.29%
Cash From Investing Activities $2.238M
YoY Change -8707.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 46.00K
Cash From Investing Activities 2.238M
Cash From Financing Activities 0.000
Net Change In Cash 2.284M
YoY Change -2.81%
FREE CASH FLOW
Cash From Operating Activities $46.00K
Capital Expenditures $32.00K
Free Cash Flow $14.00K
YoY Change -100.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments For Rent
PaymentsForRent
49000
us-gaap Payments For Rent
PaymentsForRent
99000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
29000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
25000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
32000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
39000
CY2024Q2 clir Lessee Operating Lease Liability Discounted Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityDiscountedPaymentsRemainderOfFiscalYear
43000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
49000
CY2024Q2 clir Lessee Operating Lease Liability Discounted Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths
75000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
82000
CY2024Q2 clir Lessee Operating Lease Liability Discounted Payments Due Year Two
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearTwo
63000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
67000
CY2024Q2 clir Lessee Operating Lease Liability Discounted Payments Due Year Three
LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearThree
50000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
51000
CY2024Q2 clir Lessee Operating Lease Liability Discounted Payments Due
LesseeOperatingLeaseLiabilityDiscountedPaymentsDue
231000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
249000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18000
CY2024Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1356000
CY2023Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1287000
CY2024Q2 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
90000
CY2023Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
90000
CY2024Q2 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2023Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1454000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1385000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
599000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
549000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
855000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
836000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
42000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
76000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
131000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
98000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
75000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
39000
CY2024Q2 clir Finite Lived Intangible Assets Amortization Expense Due After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseDueAfterYearFour
8000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
427000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2024Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
14000
CY2023Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
14000
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
dei Entity Central Index Key
EntityCentralIndexKey
0001434524
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50205657
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38687061
CY2024Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
CY2022Q2 clir Percentage Of Unit Holders Agreed To Extend Participation Right
PercentageOfUnitHoldersAgreedToExtendParticipationRight
0.0067
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35521
dei Entity Registrant Name
EntityRegistrantName
CLEARSIGN TECHNOLOGIES CORPORATION
dei Entity Registrant Name
EntityRegistrantName
CLEARSIGN TECHNOLOGIES CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2056298
dei Entity Address Address Line1
EntityAddressAddressLine1
8023 E. 63rd Place, Suite 101
dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa
dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74133
dei City Area Code
CityAreaCode
918
dei Local Phone Number
LocalPhoneNumber
236-6461
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
CLIR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50205657
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15974000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5684000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
287000
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
188000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
588000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
350000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
16702000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6509000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
271000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
275000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
855000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
836000
CY2024Q2 us-gaap Assets
Assets
17828000
CY2023Q4 us-gaap Assets
Assets
7620000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
453000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
366000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
88000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
71000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
430000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
703000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
825000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1116000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1796000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2256000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
143000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
172000
CY2024Q2 us-gaap Liabilities
Liabilities
1939000
CY2023Q4 us-gaap Liabilities
Liabilities
2428000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50205657
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38687061
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
5000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
112602000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98922000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-21000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-17000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96697000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93717000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15889000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5192000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17828000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7620000
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
45000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
150000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1147000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1044000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
3000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
21000
us-gaap Cost Of Revenue
CostOfRevenue
668000
us-gaap Cost Of Revenue
CostOfRevenue
809000
CY2024Q2 us-gaap Gross Profit
GrossProfit
42000
CY2023Q2 us-gaap Gross Profit
GrossProfit
129000
us-gaap Gross Profit
GrossProfit
479000
us-gaap Gross Profit
GrossProfit
235000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
402000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
187000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
683000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
347000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1777000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1571000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3185000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3221000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2179000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1758000
us-gaap Operating Expenses
OperatingExpenses
3868000
us-gaap Operating Expenses
OperatingExpenses
3568000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2137000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1629000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3389000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3333000
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
77000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
94000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
138000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
152000
CY2024Q2 us-gaap Government Assistance Nonoperating Income
GovernmentAssistanceNonoperatingIncome
185000
CY2023Q2 us-gaap Government Assistance Nonoperating Income
GovernmentAssistanceNonoperatingIncome
14000
us-gaap Government Assistance Nonoperating Income
GovernmentAssistanceNonoperatingIncome
264000
us-gaap Government Assistance Nonoperating Income
GovernmentAssistanceNonoperatingIncome
107000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
162000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
265000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
151000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
409000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
426000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1872000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1478000
us-gaap Net Income Loss
NetIncomeLoss
-2980000
us-gaap Net Income Loss
NetIncomeLoss
-2907000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47312810
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47312810
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38549810
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38549810
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43080454
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43080454
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38407053
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38407053
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-1872000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-1478000
us-gaap Profit Loss
ProfitLoss
-2980000
us-gaap Profit Loss
ProfitLoss
-2907000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-1000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-12000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-4000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-12000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1873000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1490000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2984000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2919000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5192000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
67000
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
16000
CY2024Q1 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
326000
CY2024Q1 clir Common Stock For Services Per Share Issue Two
CommonStockForServicesPerShareIssueTwo
0.81
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-1108000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4461000
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
344000
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13000
CY2024Q2 clir Common Stock For Services Per Share Issue Two
CommonStockForServicesPerShareIssueTwo
0.81
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3000
CY2024Q2 clir Stock Issued During Period Value Participation Rights Exercised
StockIssuedDuringPeriodValueParticipationRightsExercised
1447000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-1872000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15889000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9552000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
227000
CY2023Q1 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
234000
CY2023Q1 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
0.66
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1429000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8587000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
59000
CY2023Q2 clir Stock Issued During Period Shares Upon Exercise Of Options Per Share One
StockIssuedDuringPeriodSharesUponExerciseOfOptionsPerShareOne
0.54
CY2023Q2 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
0.66
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-1478000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7158000
us-gaap Profit Loss
ProfitLoss
-2980000
us-gaap Profit Loss
ProfitLoss
-2907000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
6000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
5000
us-gaap Share Based Compensation
ShareBasedCompensation
411000
us-gaap Share Based Compensation
ShareBasedCompensation
300000
clir Restricted Stock Value Reserved For Tax Withholdings
RestrictedStockValueReservedForTaxWithholdings
29000
clir Depreciation And Amortization Excluding Right Of Use Asset Amortization
DepreciationAndAmortizationExcludingRightOfUseAssetAmortization
91000
clir Depreciation And Amortization Excluding Right Of Use Asset Amortization
DepreciationAndAmortizationExcludingRightOfUseAssetAmortization
158000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
14000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
43000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
73000
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
60000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
3000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
14000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-183000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-17000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-152000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-40000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
238000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
207000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
78000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
58000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
52000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
162000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-291000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1858000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2525000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-508000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
99000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
56000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
2162000
us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
3897000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-117000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1684000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12967000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
31000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12936000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-12000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10290000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1149000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5684000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6451000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15974000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7600000
clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
326000
clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
234000
clir Prior Year Prepaid Expenses Repurposed To Fixed Assets As Demonstration Equipment
PriorYearPrepaidExpensesRepurposedToFixedAssetsAsDemonstrationEquipment
209000
clir Non Cash Impact Of New Lease
NonCashImpactOfNewLease
32000
clir Non Cash Impact Of New Lease
NonCashImpactOfNewLease
34000
CY2024Q2 clir Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
14200000
CY2024Q2 clir Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
14200000
CY2024Q2 clir Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
14200000
CY2024Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13000000.0
CY2024Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13000000.0
CY2024Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13000000.0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q2 us-gaap Research And Development Arrangement With Federal Government Customer Funding To Offset Costs Incurred
ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
0
us-gaap Research And Development Arrangement With Federal Government Customer Funding To Offset Costs Incurred
ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
107000
us-gaap Research And Development Arrangement With Federal Government Customer Funding To Offset Costs Incurred
ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
0
CY2023Q2 us-gaap Research And Development Arrangement With Federal Government Customer Funding To Offset Costs Incurred
ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
0
CY2024Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
60000
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
60000
CY2024Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
43000
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
43000
CY2024Q2 clir Construction In Progress Net
ConstructionInProgressNet
18000
CY2024Q2 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
121000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
103000
CY2024Q2 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
74000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
63000
CY2024Q2 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
47000
CY2023Q4 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
40000
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
224000
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
235000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
271000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
275000
CY2024Q2 us-gaap Depreciation
Depreciation
4000
us-gaap Depreciation
Depreciation
11000
CY2023Q2 us-gaap Depreciation
Depreciation
41000
us-gaap Depreciation
Depreciation
81000
CY2024Q2 clir Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
32000
CY2023Q2 clir Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
34000
clir Restoration Cost Payable
RestorationCostPayable
0
CY2024Q2 clir Restoration Cost Payable
RestorationCostPayable
0
CY2023Q2 clir Restoration Cost Payable
RestorationCostPayable
29000
clir Restoration Cost Payable
RestorationCostPayable
31000
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
24000
us-gaap Operating Lease Cost
OperatingLeaseCost
48000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
34000
us-gaap Operating Lease Cost
OperatingLeaseCost
82000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
224000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
235000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
88000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
71000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
143000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
172000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
231000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
243000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.054
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
45000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1147000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
668000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
150000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1044000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
809000
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
188000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
825000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1116000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1116000
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
253000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
110000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
83000
CY2023 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
105000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
82000
clir Standard Product Warranty Accrual Expirations
StandardProductWarrantyAccrualExpirations
4000
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
107000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
110000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
87500000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000.0
CY2024Q2 clir Stock Issued During Period Shares Participation Rights Exercised
StockIssuedDuringPeriodSharesParticipationRightsExercised
3350000
CY2024Q2 us-gaap Share Price
SharePrice
0.91
CY2024Q2 clir Proceeds From Exercise Of Participation Rights
ProceedsFromExerciseOfParticipationRights
4277000
CY2024Q2 clir Stock Issued During Period Value Participation Rights Exercised
StockIssuedDuringPeriodValueParticipationRightsExercised
1447000
CY2024Q2 clir Stockholders Equity Period Increase Decrease From Exercise Of Participation Rights
StockholdersEquityPeriodIncreaseDecreaseFromExerciseOfParticipationRights
4277000
CY2024Q2 us-gaap Warrants And Rights Outstanding Measurement Input
WarrantsAndRightsOutstandingMeasurementInput
5.00
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2759000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.07
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M17D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
102000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.88
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2657000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.11
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y29D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1947000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
19000
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
357000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25149000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3750000
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 clir Rule10b51arrmodifiedflag
Rule10b51arrmodifiedflag
false
CY2024Q2 clir Nonrule10b51arrmodifiedflag
Nonrule10b51arrmodifiedflag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-012226-index-headers.html Edgar Link pending
0001558370-24-012226-index.html Edgar Link pending
0001558370-24-012226.txt Edgar Link pending
0001558370-24-012226-xbrl.zip Edgar Link pending
clir-20240630.xsd Edgar Link pending
clir-20240630x10q.htm Edgar Link pending
clir-20240630xex31d1.htm Edgar Link pending
clir-20240630xex31d2.htm Edgar Link pending
clir-20240630xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
clir-20240630_def.xml Edgar Link unprocessable
clir-20240630_lab.xml Edgar Link unprocessable
clir-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clir-20240630x10q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clir-20240630_cal.xml Edgar Link unprocessable